NCT02425930: The Predictive Value of Complement C3 in Patients With Advanced Gastric Cancer |
|
|
| Completed | N/A | 85 | RoW | gastrectomy plus D2 lymphadenectomy, D2 surgery, S-1+Oxaliplatin, SOX regimen | First Affiliated Hospital, Sun Yat-Sen University | Gastric Cancer, Complement Component Deficiency, Surgery | 02/15 | 04/15 | | |
